Glioma, the most common primary intracranial tumor, poses significant challenges to precision diagnosis and treatment due to its heterogeneity and invasiveness. With the introduction of the 2021 WHO classification standard based on molecular biomarkers, the role of imaging in non-invasive subtyping and therapeutic monitoring of gliomas has become increasingly crucial. While conventional MRI shows limitations in assessing metabolic status and differentiating tumor recurrence, positron emission tomography (PET) combined with radiomics and artificial intelligence technologies offers a novel paradigm for precise diagnosis and treatment monitoring through quantitative extraction of multimodal imaging features (e.g., intensity, texture, dynamic parameters). This review systematically summarizes the technical workflow of PET radiomics (including tracer selection, image segmentation, feature extraction, and model construction) and its applications in predicting molecular subtypes (such as IDH mutation and MGMT methylation), distinguishing recurrence from treatment-related changes, and prognostic stratification. Studies demonstrate that amino acid tracers (e.g., ¹⁸F-FET, ¹¹C-MET) combined with multimodal radiomics models significantly outperform traditional parametric analysis in diagnostic efficacy. Nevertheless, current research still faces challenges including data heterogeneity, insufficient model interpretability, and lack of clinical validation. Future advancements require multicenter standardized protocols, open-source algorithm frameworks, and multi-omics integration to facilitate the transformative clinical translation of PET radiomics from research to practice.

Accurate diagnosis of pancreatic cystic lesions (PCLs) is essential to guide appropriate management and reduce unnecessary surgeries. Despite multiple guidelines in PCL management, a substantial proportion of patients still undergo major resections for benign cysts, and a majority of resected intraductal papillary mucinous neoplasms (IPMNs) show only low-grade dysplasia, leading to significant clinical, financial, and psychological burdens. This review highlights emerging endoscopic approaches that enhance diagnostic accuracy and support organ-sparing, minimally invasive management of PCLs. Recent studies suggest that endoscopic ultrasound (EUS) and its accessory techniques, such as contrast-enhanced EUS and needle-based confocal laser endomicroscopy, as well as next-generation sequencing analysis of cyst fluid, not only accurately characterize PCLs but are also well tolerated and cost-effective. Additionally, emerging therapeutics such as EUS-guided radiofrequency ablation (RFA) and EUS-chemoablation are promising as minimally invasive treatments for high-risk mucinous PCLs in patients who are not candidates for surgery. Accurate diagnosis of PCLs remains challenging, leading to many patients undergoing unnecessary surgery. Emerging endoscopic imaging biomarkers, artificial intelligence analysis, and molecular biomarkers enhance diagnostic precision. Additionally, novel endoscopic ablative therapies offer safe, minimally invasive, organ-sparing treatment options, thereby reducing the healthcare resource burdens associated with overtreatment.

Deep learning has revolutionized neuroimage analysis by delivering unprecedented speed and accuracy. However, the narrow scope of many training datasets constrains model robustness and generalizability. This challenge is particularly acute in magnetic resonance imaging (MRI), where image appearance varies widely across pulse sequences and scanner hardware. A recent domain-randomization strategy addresses the generalization problem by training deep neural networks on synthetic images with randomized intensities and anatomical content. By generating diverse data from anatomical segmentation maps, the approach enables models to accurately process image types unseen during training, without retraining or fine-tuning. It has demonstrated effectiveness across modalities including MRI, computed tomography, positron emission tomography, and optical coherence tomography, as well as beyond neuroimaging in ultrasound, electron and fluorescence microscopy, and X-ray microtomography. This tutorial paper reviews the principles, implementation, and potential of the synthesis-driven training paradigm. It highlights key benefits, such as improved generalization and resistance to overfitting, while discussing trade-offs such as increased computational demands. Finally, the article explores practical considerations for adopting the technique, aiming to accelerate the development of generalizable tools that make deep learning more accessible to domain experts without extensive computational resources or machine learning knowledge.

The prediction and management of sudden cardiac death risk continue to pose significant challenges in cardiovascular care despite advances in therapies over the last two decades. Late gadolinium enhancement (LGE) on cardiac magnetic resonance-a marker of myocardial fibrosis-is a powerful non-invasive tool with the potential to aid the prediction of sudden death and direct the use of preventative therapies in several cardiovascular conditions. In this state-of-the-art review, we provide a critical appraisal of the current evidence base underpinning the utility of LGE in both ischaemic and non-ischaemic cardiomyopathies together with a focus on future perspectives and the role for machine learning and digital twin technologies.

Large language models (LLMs) hold great promise for optimizing and supporting radiology workflows amidst rising workloads. This review examines potential applications in daily radiology practice, as well as remaining challenges and potential solutions.Presentation of potential applications and challenges, illustrated with practical examples and concrete optimization suggestions.LLM-based assistance systems have potential applications in almost all language-based process steps of the radiological workflow. Significant progress has been made in areas such as report generation, particularly with retrieval-augmented generation (RAG) and multi-step reasoning approaches. However, challenges related to hallucinations, reproducibility, and data protection, as well as ethical concerns, need to be addressed before widespread implementation.LLMs have immense potential in radiology, particularly for supporting language-based process steps, with technological advances such as RAG and cloud-based approaches potentially accelerating clinical implementation. · LLMs can optimize reporting and other language-based processes in radiology with technologies such as RAG and multi-step reasoning approaches.. · Challenges such as hallucinations, reproducibility, privacy, and ethical concerns must be addressed before widespread adoption.. · RAG and cloud-based approaches could help overcome these challenges and advance the clinical implementation of LLMs.. · Fink A, Rau S, Kästingschäfer K et al. From Referral to Reporting: The Potential of Large Language Models in the Radiological Workflow. Rofo 2025; DOI 10.1055/a-2641-3059.

To improve precision medicine in breast cancer (BC) decision-making, radio-genomics is an emerging branch of artificial intelligence (AI) that links cancer characteristics assessed radiologically with the histopathology and genomic properties of the tumour. By employing MRIs, mammograms, and ultrasounds to uncover distinctive radiomics traits that potentially predict genomic abnormalities, this review attempts to find literature that links AI-based models with the genetic mutations discovered in BC patients. The review's findings can be used to create AI-based population models for low and middle-income countries (LMIC) and evaluate how well they predict outcomes for our cohort.Magnetic resonance imaging (MRI) appears to be the modality employed most frequently to research radio-genomics in BC patients in our systemic analysis. According to the papers we analysed, genetic markers and mutations linked to imaging traits, such as tumour size, shape, enhancing patterns, as well as clinical outcomes of treatment response, disease progression, and survival, can be identified by employing AI. The use of radio-genomics can help LMICs get through some of the barriers that keep the general population from having access to high-quality cancer care, thereby improving the health outcomes for BC patients in these regions. It is imperative to ensure that emerging technologies are used responsibly, in a way that is accessible to and affordable for all patients, regardless of their socio-economic condition.

This review paper comprehensively summarizes healthcare provider (HCP) evaluation of explanations produced by explainable artificial intelligence methods to support point-of-care, patient-specific, clinical decision-making (CDM) within medical settings. It highlights the critical need to incorporate human-centered (HCP) evaluation approaches based on their CDM needs, processes, and goals. The review was conducted in Ovid Medline and Scopus databases, following the Institute of Medicine's methodological standards and PRISMA guidelines. An individual study appraisal was conducted using design-specific appraisal tools. MaxQDA software was used for data extraction and evidence table procedures. Of the 2673 unique records retrieved, 25 records were included in the final sample. Studies were excluded if they did not meet this review's definitions of HCP evaluation (1156), healthcare use (995), explainable AI (211), and primary research (285), and if they were not available in English (1). The sample focused primarily on physicians and diagnostic imaging use cases and revealed wide-ranging evaluation measures. The synthesis of sampled studies suggests a potential common measure of clinical explainability with 3 indicators of interpretability, fidelity, and clinical value. There is an opportunity to extend the current model-centered evaluation approaches to incorporate human-centered metrics, supporting the transition into practice. Future research should aim to clarify and expand key concepts in HCP evaluation, propose a comprehensive evaluation model positioned in current theoretical knowledge, and develop a valid instrument to support comparisons.

Artificial intelligence (AI)-empowered data processing tools improve our ability to assess, measure, and enhance medical interventions. AI-based tools automate the extraction of data from histories, test results, imaging, prescriptions, and treatment outcomes, and transform them into unified, accessible records. They are powerful in converting unstructured data such as clinical notes, magnetic resonance images, and electroencephalograms into structured, actionable formats. For example, in the extraction and classification of diseases, symptoms, medications, treatments, and dates from even incomplete and fragmented clinical notes, pathology reports, images, and histological markers. Especially because the demographics within correctional facilities greatly diverge from the general population, the adoption of electronic health records and AI-enabled data processing will play a crucial role in improving disease detection, treatment management, and the overall efficiency of health care within prison systems.

Severity scores, which often refer to the likelihood or probability of a pathology, are commonly provided by artificial intelligence (AI) tools in radiology. However, little attention has been given to the use of these AI scores, and there is a lack of transparency into how they are generated. In this comment, we draw on key principles from psychological science and statistics to elucidate six human factors limitations of AI scores that undermine their utility: (1) variability across AI systems; (2) variability within AI systems; (3) variability between radiologists; (4) variability within radiologists; (5) unknown distribution of AI scores; and (6) perceptual challenges. We hypothesize that these limitations can be mitigated by providing the false discovery rate and false omission rate for each score as a threshold. We discuss how this hypothesis could be empirically tested. KEY POINTS: The radiologist-AI interaction has not been given sufficient attention. The utility of AI scores is limited by six key human factors limitations. We propose a hypothesis for how to mitigate these limitations by using false discovery rate and false omission rate.

Lymphomas are a diverse group of disorders characterized by the clonal proliferation of lymphocytes. While definitive diagnosis of lymphoma relies on histopathology, immune-phenotyping and additional molecular analyses, imaging modalities such as PET/CT, CT, and MRI play a central role in the diagnostic process and management, from assessing disease extent, to evaluation of response to therapy and detecting recurrence. Artificial intelligence (AI), particularly deep learning models like convolutional neural networks (CNNs), is transforming lymphoma imaging by enabling automated detection, segmentation, and classification. This review elaborates on recent advancements in deep learning for lymphoma imaging and its integration into clinical practice. Challenges include obtaining high-quality, annotated datasets, addressing biases in training data, and ensuring consistent model performance. Ongoing efforts are focused on enhancing model interpretability, incorporating diverse patient populations to improve generalizability, and ensuring safe and effective integration of AI into clinical workflows, with the goal of improving patient outcomes.